Jul 242013

Galapagos NV announced today the achievement of a late stage discovery milestone for small molecules against a novel target in the osteoarthritis (OA) alliance with Servier.


Galapagos NV announced today the achievement of a late stage discovery milestone for small molecules against a novel target in the osteoarthritis (OA) alliance with Servier.

Sorry, the comment form is closed at this time.